Editor, Rebekah Jordan, reviews pharma's transformation to digital solutions, and how the industry will need to navigate the associated risks to prevent breaches in security and safety.
Pharma is evolving every year, but a big topic that is sticking around is digitalisation. Recently, LogiPharma reported that 86% of pharma and biotech companies planned to be more ‘digitally agile’ over the next 12 months. The main underlying reasons were to develop closer relationships with their suppliers to improve end-to-end visibility, as well as create a more operationally resilient supply chain.